SAVE 25% TODAY

For a limited time only you can gain access to a selection of reports that review the market dynamics of major disease areas and key indications to assess treatment trends, unmet needs, and topical developments, in addition to the pipeline and currently marketed products of key companies.

Pharma’s Patient Centricity

$5,000.00 $3,750.00

SAVE 25%

Find out more

Pressures and Opportunities in Pain

$7,500.00 $5,625.00

SAVE 25%

Find out more

Trends in Gene Therapy

$5,000.00 $3,750.00

SAVE 25%

Find out more

R&D Trends 2016

$5,000.00 $3,750.00

SAVE 25%

Find out more

Biosimilars Portfolio and Pipeline Trends, 2016

$5,000.00 $3,750.00

SAVE 25%

Find out more

Precision Medicine and the Future of Healthcare

$5,000.00 $3,750.00

SAVE 25%

Find out more

Data in Healthcare: Underpinning the Shift to Value

$5,000.00 $3,750.00

SAVE 25%

Find out more

Pharma Externalization Strategies 2016: Externalization is Critical to Pharma Revenue

$5,000.00 $3,750.00

SAVE 25%

Find out more

Wearables are Transforming RD and Care Delivery

$5,000.00 $3,750.00

SAVE 25%

Find out more

Prostate Cancer Pricing, Reimbursement, and Access

$7,500.00 $5,625.00

SAVE 25%

prostate-cancer-pricing-reimbursement-and-access

Find out more

Psoriatic Arthritis Pricing, Reimbursement, and Access

$7,500.00 $5,625.00

SAVE 25%

psoriatic-arthritis-pricing-reimbursement-and-access_dmkc0161763

Find out more

Psoriasis Pricing, Reimbursement, and Access

$7,500.00 $5,625.00

SAVE 25%

Find out more

Asthma Pricing, Reimbursement, and Access

$7,500.00 $5,625.00

SAVE 25%

Find out more

Q4 2016 Outlook Report

$750.00 $563.00

SAVE 25%

Find out more

Brexit And The Life Sciences: What Lies Ahead?

$700.00 $525.00

SAVE 25%

Find out more

U.S. and European Markets for Joint Arthroplasty Products

$4,750.00 $3,563.00

SAVE 25%

Find out more

Global Neurostimulation Devices Market, June 2016

$4,750.00 $3,563.00

SAVE 25%

Find out more

US Neurointerventional Devices Market, September 2016

$4,750.00 $3,563.00

SAVE 25%

Find out more